Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.berh.2014.03.002 http://scihub22266oqcxt.onion/10.1016/j.berh.2014.03.002 C4074772!4074772 !24974063     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\24974063 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Best+Pract+Res+Clin+Rheumatol 2014 ; 28 (2 ): 277-92 Nephropedia Template TP {{tp|p=24974063 |t=2014. Macrophage activation syndrome and cytokine-directed therapies |pdf=|usr=}}{{24974063 }} gab.com Text Macrophage activation syndrome and cytokine-directed therapies JO: Best Pract Res Clin Rheumatol http://www.kidney.de/pget.php?&tw=1&pmid=24974063 #FOAvip Macrophage activation syndrome (MAS) is an episode of overwhelming inflammation that occurs most commonly in children with systemic juvenile idiopathic arthritis (SJIA). It is characterized by expansion and activation of T lymphocytes and hemophagocytic macrophages and bears great similarity to hemophagocytic lymphohistiocytosis (HLH). This disorder has substantial morbidity and mortality, and there is frequently a delay in recognition and initiation of treatment. Here, we will review what is known about the pathogenesis of MAS and, in particular, its similarities to HLH. The development of MAS is characterized by a cytokine storm, with the elaboration of numerous pro-inflammatory cytokines. We will examine the evidence for various cytokines in the initiation and pathogenesis of MAS and discuss how new biologic therapies may alter the risk of MAS. Finally, we will review current treatment options for MAS and examine how cytokine-directed therapy could serve as novel treatment modalities. Twit Text FOAVip Macrophage activation syndrome and cytokine-directed therapies ????Best Pract Res Clin Rheumatol http://www.kidney.de/pget.php?&tw=1&pmid=24974063 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=24974063 #FOAvip English Wikipedia <ref>{{Cite pmid|24974063 }}</ref> Macrophage activation syndrome and cytokine-directed therapies #MMPMID24974063 Schulert GS ; Grom AA Best Pract Res Clin Rheumatol 2014[Apr]; 28 (2 ): 277-92 PMID24974063 show ga Macrophage activation syndrome (MAS) is an episode of overwhelming inflammation that occurs most commonly in children with systemic juvenile idiopathic arthritis (SJIA). It is characterized by expansion and activation of T lymphocytes and hemophagocytic macrophages and bears great similarity to hemophagocytic lymphohistiocytosis (HLH). This disorder has substantial morbidity and mortality, and there is frequently a delay in recognition and initiation of treatment. Here, we will review what is known about the pathogenesis of MAS and, in particular, its similarities to HLH. The development of MAS is characterized by a cytokine storm, with the elaboration of numerous pro-inflammatory cytokines. We will examine the evidence for various cytokines in the initiation and pathogenesis of MAS and discuss how new biologic therapies may alter the risk of MAS. Finally, we will review current treatment options for MAS and examine how cytokine-directed therapy could serve as novel treatment modalities. |Animals [MESH] |Arthritis, Juvenile/drug therapy/*immunology [MESH] |Biological Factors/therapeutic use [MESH] |Cytokines/antagonists & inhibitors/*physiology [MESH] |Disease Models, Animal [MESH] |Humans [MESH] |Interleukin-1/*antagonists & inhibitors [MESH] |Interleukin-6/*antagonists & inhibitors [MESH] |Lymphohistiocytosis, Hemophagocytic/etiology [MESH] |Macrophage Activation Syndrome/drug therapy/*immunology [MESH]Macrophage activation syndrome and cytokine-directed therapies (epmc).pdf DeepDyve Pubget Overpricing